The HSP-derived bioactive peptides made by Girgih et al. [25] were able to lower SBP in adult SHRs with established hypertension and decreased SBP in young growing SHRs to a greater extent than the HSP isolate when substituted for casein at 1%. This evidence concerns the gene HSP90B2P and hypertensive disorder.